These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 35373779)

  • 21. "Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents: A pediatric case report": Comment.
    Kleebayoon A; Wiwanitkit V
    Pediatr Neonatol; 2023 Nov; 64(6):696. PubMed ID: 37270340
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of Appendicitis After mRNA COVID-19 Vaccination in a Danish Population.
    Kildegaard H; Ladebo L; Andersen JH; Jensen PB; Rasmussen L; Damkier P; Pottegård A
    JAMA Intern Med; 2022 Jun; 182(6):684-686. PubMed ID: 35467699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
    Haslak F; Gunalp A; Cebi MN; Yildiz M; Adrovic A; Sahin S; Barut K; Kasapcopur O
    Int J Rheum Dis; 2022 Mar; 25(3):353-363. PubMed ID: 34978376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist.
    Pulsipher KJ; Presley CL; Waller JD; Szeto MD; Laughter MR; Dellavalle RP
    J Drugs Dermatol; 2021 Mar; 20(3):351-352. PubMed ID: 33683080
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis.
    Faissner S; Richter D; Ceylan U; Schneider-Gold C; Gold R
    J Neurol; 2022 Apr; 269(4):1774-1775. PubMed ID: 34435250
    [No Abstract]   [Full Text] [Related]  

  • 26. Inadvertent subcutaneous injection of COVID-19 vaccine.
    Ng JY
    Postgrad Med J; 2021 Jun; 97(1148):400. PubMed ID: 33589486
    [No Abstract]   [Full Text] [Related]  

  • 27. Morphea and COVID-19 mRNA vaccine.
    Sookaromdee P; Wiwanitkit V
    Int J Dermatol; 2022 May; 61(5):e162. PubMed ID: 35230704
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.
    Greenberg RS; Ruddy JA; Boyarsky BJ; Werbel WA; Garonzik-Wang JM; Segev DL; Imus PH
    BMC Cancer; 2021 Dec; 21(1):1354. PubMed ID: 34961488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newly-developed vitiligo following COVID-19 mRNA vaccine.
    Uğurer E; Sivaz O; Kıvanç Altunay İ
    J Cosmet Dermatol; 2022 Apr; 21(4):1350-1351. PubMed ID: 35152540
    [No Abstract]   [Full Text] [Related]  

  • 30. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease.
    Spiera E; Agrawal M; Ungaro RC
    Gastroenterology; 2022 Mar; 162(3):987-988. PubMed ID: 34626602
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.
    Metin Z; Celepli P
    Int J Dermatol; 2022 May; 61(5):639-641. PubMed ID: 35073411
    [No Abstract]   [Full Text] [Related]  

  • 33. Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.
    Miyazato Y; Yamamoto K; Yamada G; Kubota S; Ishikane M; Sugiyama M; Ueno M; Matsunaga A; Miyoshi-Akiyama T; Ishizaka Y; Ohmagari N
    Emerg Infect Dis; 2022 Apr; 28(4):870-872. PubMed ID: 35148495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre.
    Koumaki D; Krueger-Krasagakis SE; Papadakis M; Katoulis AC; Gkiaouraki I; Zografaki K; Mylonakis D; Krasagakis K
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e411-e415. PubMed ID: 35075691
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
    Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
    Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
    [No Abstract]   [Full Text] [Related]  

  • 36. Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers.
    Luk A; Clarke B; Dahdah N; Ducharme A; Krahn A; McCrindle B; Mizzi T; Naus M; Udell JA; Virani S; Zieroth S; McDonald M
    Can J Cardiol; 2021 Oct; 37(10):1629-1634. PubMed ID: 34375696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence.
    Pan W; Yu D; Shi N; Bao Z
    Hum Vaccin Immunother; 2023 Dec; 19(3):2286117. PubMed ID: 37992397
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
    Masset C; Benotmane I; Dantal J; Garandeau C; Gauthier-Vargas G; Cantarovich D; Meurette A; Giral M; Caillard S; Blancho G
    Kidney Int; 2022 Apr; 101(4):825-826. PubMed ID: 35167873
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose.
    Van Meerbeke SW; Fajt ML; Marini RV; Domsic RT; Petrov AA
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):373-374. PubMed ID: 35595005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.